Target intelligence / Profile preview

Iron-responsive element in the 5'-untranslated region of Amyloid Precursor Protein mRNA (APP 5'-UTR IRE)

Target
APP 5'-UTR IRE
Molecular classification
RNA regulatory element, Non-coding RNA, Other
01

Overview

The iron-responsive element (IRE) in the 5'-untranslated region (UTR) of the Amyloid Precursor Protein (APP) mRNA is a specialized RNA stem-loop structure that controls the rate of APP protein synthesis based on cellular iron availability (Rogers et al., 2002, J Biol Chem). In the presence of low intracellular iron, Iron Regulatory Proteins (IRP1 and IRP2) bind to this IRE, physically blocking the translation machinery from initiating protein synthesis. When iron levels are high, IRPs dissociate, permitting the translation of APP, which has been linked to iron export and neuronal homeostasis (Cho et al., 2010, J Biol Chem). Dysregulation of this system can lead to the overproduction of APP, a precursor to the amyloid-beta (Aβ) peptides that aggregate into plaques in Alzheimer's disease (Bandyopadhyay et al., 2013, Gene). Therapeutic strategies involve using small molecules, such as Posiphen, which bind to or stabilize the IRE-IRP interaction to downregulate APP translation (Muckenthaler et al., 2008, Cell). This approach aims to reduce the total burden of Aβ in the brain by limiting the production of its precursor at the translational level rather than inhibiting the secretase enzymes responsible for its cleavage.

Other names
APP IREAmyloid precursor protein iron-responsive element5'-UTR IRE of APPAPP 5'-untranslated region iron-responsive element
02

Mechanism of action

Small molecule binding to the 5'-UTR IRE of APP mRNA to inhibit translation and reduce the production of Amyloid Precursor Protein.

03

Biological functions

Translation regulationIron homeostasisProtein synthesisCellular iron sensing
04

Disease associations

Alzheimer's diseaseNeurodegenerative diseaseParkinson's diseaseCerebral amyloid angiopathy
05

Safety considerations

Off-target effects on other IRE-containing mRNAs (e.g., ferritin, transferrin receptor)Systemic iron metabolism disruptionPotential for unintended suppression of neuroprotective sAPPα
06

Interacting drugs

Posiphen (Phenserine enantiomer)

2 more in the full profile.

07

Biomarkers

Amyloid-beta 42 (Aβ42) levelsSoluble Amyloid Precursor Protein alpha (sAPPα)Soluble Amyloid Precursor Protein beta (sAPPβ)Total Tau protein

Beyond the preview

Go deeper on Iron-responsive element in the 5'-untranslated region of Amyloid Precursor Protein mRNA (APP 5'-UTR IRE).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Iron-responsive element in the 5'-untranslated region of Amyloid Precursor Protein mRNA (APP 5'-UTR IRE).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call